A quantitative model used to compare within-host SARS-CoV-2, MERS-CoV, and SARS-CoV dynamics provides insights into the pathogenesis and treatment of SARS-CoV-2

A quantitative model used to compare within-host SARS-CoV-2, MERS-CoV, and SARS-CoV dynamics provides insights into the pathogenesis and treatment of SARS-CoV-2

The scientific community is focused on developing antiviral therapies to mitigate the impacts of the ongoing novel coronavirus disease 2019 (COVID-19) outbreak. This will be facilitated by improved understanding of viral dynamics within infected hosts. Here, using a mathematical model in combination...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Kim, KS, Ejima, K, Iwanami, S, Fujita, Y, Ohashi, H, Koizumi, Y, Asai, Y, Nakaoka, S, Watashi, K, Aihara, K, Thompson, RN, Ke, R, Perelson, AS, Iwami, S
Format:	Journal article
Język:	English
Wydane:	Public Library of Science 2021

Podobne zapisy

A quantitative model used to compare within-host SARS-CoV-2, MERS-CoV, and SARS-CoV dynamics provides insights into the pathogenesis and treatment of SARS-CoV-2.
od: Kwang Su Kim, i wsp.
Wydane: (2021-03-01)

Comparative highlights on MERS-CoV, SARS-CoV-1, SARS-CoV-2, and NEO-CoV
od: Rajat Goyal, i wsp.
Wydane: (2022-09-01)

A Review of SARS-CoV2: Compared With SARS-CoV and MERS-CoV
od: Huan Zhou, i wsp.
Wydane: (2021-12-01)

Diabetes and coronavirus infections (SARS-CoV, MERS-CoV, and SARS-CoV-2)
od: Azadeh Haghi Navand, i wsp.
Wydane: (2020-01-01)

Data mining of coronavirus: SARS-CoV-2, SARS-CoV and MERS-CoV
od: Jung Eun Huh, i wsp.
Wydane: (2021-04-01)

SARS-CoV-2, the other face to SARS-CoV and MERS-CoV: Future predictions
od: T.M. Abdelghany, i wsp.
Wydane: (2021-03-01)

Computational analysis of SARS-CoV-2, SARS-CoV, and MERS-CoV genome using MEGA
od: Vipan Kumar Sohpal
Wydane: (2020-09-01)

The Comparison of SARS-CoV-2, SARS-CoV, and MERS-CoV Genome and Spike Protein Variations
od: Choirun Nita Fikriani, i wsp.
Wydane: (2021-03-01)

The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections
od: Yun-yu Zhang, i wsp.
Wydane: (2020-08-01)

Computational designing of a peptide that potentially blocks the entry of SARS-CoV, SARS-CoV-2 and MERS-CoV.
od: Priya V K, i wsp.
Wydane: (2021-01-01)

Comparison of the Characteristics of Cytokine Storm and Immune Response Induced by SARS-CoV, MERS-CoV, and SARS-CoV-2 Infections
od: Liu T, i wsp.
Wydane: (2021-10-01)

Autopsy Tool in Unknown Diseases: The Experience with Coronaviruses (SARS-CoV, MERS-CoV, SARS-CoV-2)
od: Francesco Sessa, i wsp.
Wydane: (2021-03-01)

An Exploration of Nanoparticle-Based Diagnostic Approaches for Coronaviruses: SARS-CoV-2, SARS-CoV and MERS-CoV
od: Ahmed Al-Hindawi, i wsp.
Wydane: (2022-10-01)

Comparative Review of SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza A Respiratory Viruses
od: Zeinab Abdelrahman, i wsp.
Wydane: (2020-09-01)

Susceptibility to SARS-CoV-2 and MERS-CoV in Beagle Dogs
od: Kwang-Soo Lyoo, i wsp.
Wydane: (2023-02-01)

Lack of Susceptibility to SARS-CoV-2 and MERS-CoV in Poultry
od: David L. Suarez, i wsp.
Wydane: (2020-12-01)

Innate Immunity Evasion Strategies of Highly Pathogenic Coronaviruses: SARS-CoV, MERS-CoV, and SARS-CoV-2
od: Jin-Yan Li, i wsp.
Wydane: (2021-10-01)

Comparison of the SARS-CoV-2 (2019-nCoV) M protein with its counterparts of SARS-CoV and MERS-CoV species
od: Sultan Nafea Alharbi, i wsp.
Wydane: (2021-03-01)

Lessons from SARS-CoV, MERS-CoV, and SARS-CoV-2 Infections: What We Know So Far
od: Radi Taha Alsafi
Wydane: (2022-01-01)

Detailed Molecular Interactions of Favipiravir with SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza Virus Polymerases In Silico
od: Mitsuru Sada, i wsp.
Wydane: (2020-10-01)

Long-Term Health Consequences of SARS-CoV-2: Assumptions Based on SARS-CoV-1 and MERS-CoV Infections
od: Ashutosh Khaswal, i wsp.
Wydane: (2022-07-01)

Coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 helicase inhibitors: a systematic review of in vitro studies
od: Nimer Mehyar
Wydane: (2023-06-01)

Trends in MERS-CoV, SARS-CoV, and SARS-CoV-2 (COVID-19) Diagnosis Strategies: A Patent Review
od: José Adão Carvalho Nascimento Junior, i wsp.
Wydane: (2020-10-01)

Differential Tropism of SARS-CoV and SARS-CoV-2 in Bat Cells
od: Susanna K.P. Lau, i wsp.
Wydane: (2020-12-01)

Comprehensive Structural and Molecular Comparison of Spike Proteins of SARS-CoV-2, SARS-CoV and MERS-CoV, and Their Interactions with ACE2
od: Ma’mon M. Hatmal, i wsp.
Wydane: (2020-12-01)

Potential recombination between SARS-CoV-2 and MERS-CoV: calls for the development of Pan-CoV vaccines
od: Qiao Wang, i wsp.
Wydane: (2023-03-01)

Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection
od: Yanwen Liang, i wsp.
Wydane: (2020-05-01)

Amyloidogenic proteins in the SARS-CoV and SARS-CoV-2 proteomes
od: Taniya Bhardwaj, i wsp.
Wydane: (2023-02-01)

Comparing and Contrasting MERS, SARS-CoV, and SARS-CoV-2: Prevention, Transmission, Management, and Vaccine Development
od: Mohammad Oves, i wsp.
Wydane: (2020-11-01)

Comparison and Analysis of Neutralizing Antibody Levels in Serum after Inoculating with SARS-CoV-2, MERS-CoV, or SARS-CoV Vaccines in Humans
od: Sicong Yu, i wsp.
Wydane: (2021-06-01)

Plant Alkaloids Inhibit Membrane Fusion Mediated by Calcium and Fragments of MERS-CoV and SARS-CoV/SARS-CoV-2 Fusion Peptides
od: Egor V. Shekunov, i wsp.
Wydane: (2021-10-01)

Unlocking COVID therapeutic targets: A structure-based rationale against SARS-CoV-2, SARS-CoV and MERS-CoV Spike
od: João Trigueiro-Louro, i wsp.
Wydane: (2020-01-01)

Product of natural evolution (SARS, MERS, and SARS-CoV-2); deadly diseases, from SARS to SARS-CoV-2
od: Mohamad Hesam Shahrajabian, i wsp.
Wydane: (2021-01-01)

Contrasting roles of MERS-CoV and SARS-CoV-2 internal proteins in pathogenesis in mice
od: Lok-Yin Roy Wong, i wsp.
Wydane: (2023-12-01)

Molecular Basis of the Structure and Transmission of SARS-CoV, SARS-CoV-2, and MERS: A Review Report
od: Dr. Saima Naz, i wsp.
Wydane: (2023-06-01)

Co-infection of MERS-CoV and SARS-CoV-2 in the same host: A silent threat
od: Buket Baddal, i wsp.
Wydane: (2020-09-01)

Source of the COVID-19 pandemic: ecology and genetics of coronaviruses (Betacoronavirus: Coronaviridae) SARS-CoV, SARS-CoV-2 (subgenus Sarbecovirus), and MERS-CoV (subgenus Merbecovirus)
od: Dmitry K. Lvov, i wsp.
Wydane: (2020-05-01)

Viral shadows in the Middle East: Revisiting MERS-CoV Post SARS-CoV2
od: Mohammad Shenagari, i wsp.
Wydane: (2024-03-01)

Use of Complementary Medicine in SARS-CoV-2 and MERS-CoV: a Narrative Review
od: Maryam Rahmannia, i wsp.
Wydane: (2022-05-01)

Fluoroquinolone Antibiotics Exhibit Low Antiviral Activity against SARS-CoV-2 and MERS-CoV
od: Stacey L. P. Scroggs, i wsp.
Wydane: (2020-12-01)